Renal bone disease 1990: an unmet challenge for the nephrologist.
about
Chronic kidney disease mineral and bone disorder in childrenBone as a possible target of chemical toxicity of natural uranium in drinking water.Vitamin D prohormone in the treatment of secondary hyperparathyroidism in patients with chronic kidney disease.Exposure to multiple metals from groundwater-a global crisis: geology, climate change, health effects, testing, and mitigation.Hypertension and hematologic parameters in a community near a uranium processing facility.Chronic kidney disease: mineral and bone disorder in children.Sclerostin and Dickkopf-1 in renal osteodystrophy.Is gastrectomy-induced high turnover of bone with hyperosteoidosis and increase of mineralization a typical osteomalacia?The roles of the skeleton and phosphorus in the CKD mineral bone disorderThe link between bone and coronary calcifications in CKD-5 patients on haemodialysisThe five most commonly used intact parathyroid hormone assays are useful for screening but not for diagnosing bone turnover abnormalities in CKD-5 patientsRelationship between the serum parathyroid hormone and magnesium levels in continuous ambulatory peritoneal dialysis (CAPD) patients using low-magnesium peritoneal dialysateEffect of risedronate on bone in renal transplant recipients.Chronic Renal Failure: Determining the causeSecondary hyperparathyroidism in chronic kidney disease: focus on clinical consequences and vitamin D therapies.Bone densitometric analysis in egyptian hemodialysis patients.Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure.Cardiovascular risk in chronic kidney disease (CKD): the CKD-mineral bone disorder (CKD-MBD).Relationship between plasma fibroblast growth factor-23 concentration and bone mineralization in children with renal failure on peritoneal dialysis.Cholecalciferol (vitamin D3) therapy and vitamin D insufficiency in patients with chronic kidney disease: a randomized controlled pilot study.Role of Bcl2 in osteoclastogenesis and PTH anabolic actions in boneBisphosphonate-induced Severe Hypocalcemia - A Case Report -.Role of bone biopsy in stages 3 to 4 chronic kidney disease.The osteocyte in CKD: new concepts regarding the role of FGF23 in mineral metabolism and systemic complications.Review of cinacalcet hydrochloride in the management of secondary hyperparathyroidism.Aluminum Chloride Induces Osteoblasts Apoptosis via Disrupting Calcium Homeostasis and Activating Ca(2+)/CaMKII Signal Pathway.The whole-PTH/intact-PTH ratio is a useful predictor of severity of secondary hyperparathyroidism.Bone lead measurements in patients with chronic renal disease studied over time.Hypercalcaemia: changing causes over the past 10 years.Noninvasive assessment of bone health in Indian patients with chronic kidney disease.Increased osteocyte death and mineralization inside bone after parathyroidectomy in patients with secondary hyperparathyroidism.Effective use of cinacalcet for the treatment of secondary hyperparathyroidism in Austrian dialysis patients--results of the Austrian cohort of the ECHO study.Effect of 18 months of treatment with alfacalcidol on bone in patients with mild to moderate chronic renal failure.Prevalence of low trauma fractures in long-term kidney transplant patients with preserved renal function.Serum fibroblast growth factor-23 (FGF-23) and fracture risk in elderly menImpact of lanthanum carbonate on cortical bone in dialysis patients with adynamic bone disease
P2860
Q24642788-982E52F2-3740-44AB-8FB6-AFACFA3B30B0Q24811296-D4F3AFB7-767C-484B-91B7-E3BF57DD0A13Q33703957-89BD4B62-09A0-408B-BDE9-E84B38F09A31Q33964023-350BA15A-E74A-43CB-A4F6-A3C90F6ACE79Q34299415-727BF519-7734-41B3-8C26-1A59681FB0D6Q34402661-B0910F5B-AD80-48E8-96C7-798721A4E19AQ34751932-CF5F72A3-A334-4667-BA90-E0227F0E15BCQ34775881-3FFB7818-3B97-4D5E-94D6-541647EADED9Q35013304-F350A10D-5D99-466B-B0B9-01C5EC2C14EEQ35025415-1EB36F76-7516-4EEA-A2D0-15FD60AFC644Q35848015-D46B4F66-7E2F-40C1-82FC-D25726C99177Q35937318-216A4007-4B5F-4C48-92D8-599AFBB63CBAQ36109164-0EAC99B2-BA9B-4661-9603-5C95DE181F54Q36283907-7F8BB6A1-F1B2-42DE-AA91-7F1AD3858477Q36567144-929DEEF2-CAD6-4504-893D-AA604184ED7CQ36735406-50F01C07-63D2-4C1A-B173-8454BC5D430EQ36902283-36E8206E-AFA2-4E94-A8A4-FEC193F27B24Q37035502-16C78CF6-CE36-40E3-92DE-48DD81205128Q37106569-AABAB3AD-E780-4C5C-9263-C80B438F53CEQ37125654-43B70787-CCCA-4038-9354-42A4B9AC266CQ37172756-75C9E91D-0419-4D98-B22A-2AC49D891C93Q37192055-23AD59B2-AF93-48E0-BFDC-E74D104DF029Q37319136-F9323722-4802-4408-86F4-96AAADEDA8ABQ38053246-421C1772-BE1F-46BA-90F4-6074281BC844Q38141236-432F7964-E230-497E-8F36-0AFB1160A7A9Q38297847-4DAC758D-DEED-495D-A8DB-94CDA4421168Q40318220-A12E749C-965A-441F-A637-D3C108719FC5Q41101751-52BBF5F2-6CA2-4C4B-81ED-4CE32AF5CB53Q41930902-C9D40333-3ADB-4C60-BF1F-FA0DA8DFE539Q42092498-A350A46B-5575-48E8-BFE3-8EC27995F3B6Q43055101-A4E62A20-56E0-4B45-AF6A-9ACE47060849Q44186583-5F26AA97-DEF8-4E5B-94FB-9E084A46E012Q44805620-D5B6C21E-4D0A-4DB7-AA00-A0F13F86858AQ46885147-CBD7B7CB-74F1-49BA-830D-E547DCD4D5F5Q56109733-89AA72E6-D2B0-4D18-A7EB-C95864E88D3CQ57217879-CE0A036B-C683-408B-B574-051256A67074
P2860
Renal bone disease 1990: an unmet challenge for the nephrologist.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Renal bone disease 1990: an unmet challenge for the nephrologist.
@en
Renal bone disease 1990: an unmet challenge for the nephrologist.
@nl
type
label
Renal bone disease 1990: an unmet challenge for the nephrologist.
@en
Renal bone disease 1990: an unmet challenge for the nephrologist.
@nl
prefLabel
Renal bone disease 1990: an unmet challenge for the nephrologist.
@en
Renal bone disease 1990: an unmet challenge for the nephrologist.
@nl
P356
P1433
P1476
Renal bone disease 1990: an unmet challenge for the nephrologist.
@en
P2093
H Malluche
M C Faugere
P2888
P304
P356
10.1038/KI.1990.187
P407
P577
1990-08-01T00:00:00Z